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httpcense.Abstract Aim: To evaluate the radiological signs of gastro-intestinal inﬂammation at CT enterog-
raphy and to assess its accuracy in determining the degree of activity in patients with Crohn’s dis-
ease (CD).
Methods: CT enterography was performed in 26 CD patients and evaluated for the following
parameters: mucosal enhancement, abnormal wall thickening, engorged vasa recta, increased den-
sity of the mesenteric fat and enlarged mesenteric lymph nodes. Correlations between CT ﬁndings
and histopathologic results were made using McNemar test.
Results: There was no signiﬁcant statistical difference in mucosal enhancement and wall thickening
between moderate and severe disease (P= 0.631 and 0.138, respectively) whereas engorged vasa
recta, fat edema and lymph node enlargement had successfully discriminated between moderate
and severe histological ﬁndings (P= 0.009, <0.001 and 0.045, respectively). Moderate disease
was diagnosed correctly by CTE in 50% of cases while severe disease was diagnosed in 100% of
cases. When we reconditioned the presence of two CTE severity criteria to diagnose severe disease,
the sensitivity to predict moderate disease activity increased to 80%.
Conclusion: CT enterography is a sensitive and speciﬁc non-invasive imaging modality for evaluat-
ing the degree of activity of Crohn’s disease, and should be considered in its diagnostic and man-
agement algorithms.
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Assessment of activity in Crohn’s disease (CD) is crucial to
patient’s management and to monitor the effect of therapy.
Activity of CD is usually assessed by clinical data, endoscopy,
or serum biochemical markers such as erythrocyte sedimenta-
tion rate (ESR) and C reactive protein (CRP). However,Production and hosting by Elsevier B.V.
.05.005
354 A.M. Mohamed et al.endoscopy only assesses the superﬁcial mucosa and does not
evaluate the transmural inﬂammatory process in Crohn’s dis-
ease. Also inﬂammatory markers are not fully understood in
CD despite their frequent use (1). Although small bowel follow
through can deﬁne the extent and severity of narrowing, it pro-
vides little data on whether narrowing results from inﬂamma-
tion or stricture, and lacks the information about the extra
enteric manifestations (2). Computed tomography (CT) is cur-
rently used for the detection of possible complications of CD
like ﬁstula, abscesses, or stricture/obstruction, but also holds
promise in the assessment of disease activity (3). There are
many advantages of CT from the patient’s perspective com-
pared to small bowel follow through including no tender palpa-
tion or change of position, only requires getting on/off the table
once, and much less time required (4). CT enterography (CTE)
differs from conventional abdominal CT scanning techniques
in utilizing multi-detector CT with its high spatial and temporal
resolution, thus providing thin slice data that combine the
advantages of gastro-intestinal volume challenge with the abil-
ity of cross-sectional imaging and multi-planar reformatting to
depict extra luminal manifestations of the disease (5). Large
volumes of water-attenuation bowel contrast and intravenous
contrast improve visualization of the small bowel lumen and
wall (6). Abnormal wall enhancement/thickening, increased
density and smudging of the mesenteric fat, engorged vasa recta
‘‘comb sign’’ and possibly enlarged mesenteric lymph nodes
have been shown to correlate with active inﬂammation (7,8).
The aim of this work is to assess the accuracy of CTE in
detecting the degree of activity in patients with Crohn’s disease
through the correlation between the histopathologic results
and CTE ﬁndings of inﬂammatory activity.
2. Patients and methods
This study was carried out in the Radiodiagnosis Department
units of Ain Shams University Hospital and in some private
centers. The study design consisted of 26 patients (18 males
and 8 females) with known CD during the period from June
2010 to November 2011. The average patient’s age was
43.4 years (range = 19–69 years). All included patients were re-
ferred to further assessment with CTE and an informed consent
was obtained from each patient before the study. Determina-
tion of disease activity was done by a gastroenterologist
through the calculation of the disease activity index (CDAI)
on the basis of the following data: the number of liquid or very
soft stools per week, ratings of abdominal pain and general well-
being, hematocrit level, height and body weight, presence of a
palpable mass, and presence of complications. Disease was clas-
siﬁed as active if the CDAI was 6150 (9).
The diagnosis of Crohn’s disease and evaluation of its activ-
ity were based on the pathologic ﬁndings. In most patients the
ileo-cecal junction was involved, so in 21 patients an ileo-colon-
oscopy was performed within one week before CT examination
in whom at least the last 10 cm of the terminal ileum was scoped
and biopsy was taken. One patient with gastric involvement was
diagnosed by gastroscopy. Endoscopic signs of active disease in-
cluded aphthous ulcers, mucosal erythema and edema, inﬂam-
matory nodularity or cobble stoning, spontaneous bleeding
and friability. In four patients, the pathological diagnosis was
made after segmental small bowel resection for painful ﬁbrotic
stricture or subacute obstruction. The severities of acute andchronic disease by histology were graded based on the greatest
severity of inﬂammation as mild, moderate or severe.
CTE technique
The patients were instructed to drink an amount of water rang-
ing between 1 and 1.5 l within 2 h prior to the examination
according to their tolerance, with one last cup administered
immediately before the examination. TheCT examinationswere
performed by at least eight multi-detector scanners (GEHealth-
care,Milwaukee,WI,USA). IV contrast (Iopamiro 300; Bracco,
Milano, Italy) was given as 100–150 ml at a rate of 4 ml/s using
an automatic pump injector via an antecubital or peripheral
upper limb vein. Scanning was initiated 60 s after the start of
the injection, with 2.5-slice collimation, 3-mm slice thickness,
1.5 reconstruction intervals, and a kV of 140. The images were
sent to a workstation where coronal and sometimes sagittal
reformats were reconstructed. Viewing of the coronal reformats
was more assuring to the viewer in detection of the site of
abnormality especially when the involved segments were ade-
quately distended as the transition point between normal and
diseased segments could be more easily determined.
The images were reviewed by an experienced radiologist for
the following ﬁndings: mucosal enhancement, bowel wall
thickening (>3 mm), edema of the mesenteric fat, engorged
vasa recta, lymphadenopathy and possible complications like
ﬁstula or abscess. Mural enhancement was considered when
segmental enhancement of the bowel wall was greater than
enhancement of the adjacent bowel loops. Increased density/
smudging of the peri-enteric fat was deﬁned by increased inho-
mogeneous attenuation of the fat as compared with the subcu-
taneous fat, peri-nephric fat or peri-enteric fat adjacent to
normal bowel loops. The comb sign is deﬁned as dilatation
of the vasa recta involving the offended bowel loop (10).
Positive enteral contrast was used in some patients for
whom the examinations were done in private centers; however,
we were able to enroll these cases in the study because the af-
fected bowel segments were not opaciﬁed, and we could reli-
ably assess the degree of mucosal enhancement.
Mild disease was deﬁned at CTE by mucosal hyper
enhancement only, while moderate disease was classiﬁed as
abnormal mucosal enhancement and wall thickening. Severe
disease was considered if one or more of the extra-enteric man-
ifestations were detected in addition to the moderate activity
criteria (11).
3. Results
Twenty-six patients were included in the study. There were 18
males and 8 females. Median age was 43.4 years (range 19–69).
The patients were on no treatment for three days prior to the
CTE study irrespective of the type of treatment. The radiolog-
ical ﬁndings were correlated with the histopathological results
for all cases. Sixteen patients were histologically diagnosed
with severe disease (61%) while 10 patients were diagnosed
as having moderate disease (39%) (Fig. 1).
CTE revealed mucosal enhancement in almost all patients
(25 patients; 96%), but not appreciated in one patient with
moderately active disease. Wall thickening was present in 24
patients (92%) but not appreciated in two cases with moderate
disease activity at endoscopy, one of them was under graded as
Fig. 1 Moderate degree of diseased activity. A 22 year old male with CD presented with increasing abdominal pain and diarrhea. (A)
Axial and (B) coronal CTE show wall thickening and mucosal enhancement at the terminal ileum (arrows).
Role of CT enterography in assessment of Crohn’s disease activity: Correlation with histopathologic diagnosis 355mild (Fig. 2). Engorged vasa recta were present in 14 patients
(53%) and diagnosed by CT as severe inﬂammation (Figs. 3
and 4); their histopathological results conﬁrmed severity of
inﬂammation in 12 patients, while the other two were diag-
nosed as moderate. Mesenteric fat edema and smudging were
present in 19 patients (73%); histopathological results revealed
severe inﬂammation in 16 of them (Fig. 4) and moderate dis-
ease in three patients (Fig. 5). Enlarged mesenteric lymph
nodes were present in nine patients (35%); eight of them had
severe disease by histopathology (Fig. 3), while the remaining
one had moderate disease activity. No gross complications of
Crohn’s disease like abscess or ﬁstula were encountered in
our groups of patients, but four patients with severe diseaseFig. 2 Mild disease activity at CTE but histologically moderate
degree. A 40 year old man with CD presented with abdominal
pain and repeated vomiting. CTE coronal reformatted image
shows intense gastric mucosal hyper enhancement (arrowed) that
was interpreted as mild active disease. However, gastroscopic
tissue sampling revealed moderate disease activity.had ﬁbrotic inﬂammatory strictures causing pain and subacute
obstruction, for whom segmental small bowel resection was
done (Fig. 6).
Table 1 shows the association between CT ﬁndings and his-
tological ﬁndings in our patients’ population.
In our study, moderate disease was diagnosed correctly by
CTE in 5 out of 10 patients (50%) (Fig. 1). The remaining ﬁve
patients were diagnosed as severe in four cases where they
showed only one sign of severe activity (engorged vasa recta,
mesenteric fat edema, or lymphadenopathy) (Fig. 5), and as
mild activity in one case that showed only mucosal enhance-
ment (Fig. 2). All patients with severe disease (16 cases) were
diagnosed correctly by CTE (100%). Each of them was having
at least two criteria of severe disease (Figs. 3 and 4).
Table 2 depicts histological activity and CT scan parame-
ters of activity in our patients’ population.
If we consider the presence of any two of the following:
engorged vasa recta, fat edema and lymph nodes as ‘‘severe’’
in classiﬁcation of CTE ﬁndings, the correlation with the histo-
logical results would be of greater sensitivity (80%) of predict-
ing moderate disease activity (Table 3).
4. Discussion
Crohn’s disease (CD) is an incurable chronic condition that
can affect any part of the gastro-intestinal tract. Frequently
it is manifested by abdominal pain but it is often not clear
whether this pain is caused by active inﬂammation, by stenosis
and proximal dilatation, or both. Moreover, there is a high
prevalence of extra enteric manifestation of the disease that
can signiﬁcantly alter management plans, including the initia-
tion of antibiotic therapy, surgical referral and/or the use of
immunosuppressive or biologic agents (12). Computed tomog-
raphy enterography (CTE) has been recently applied to the
study of Crohn’s disease due to its ability to non-invasively
differentiate which process is predominant, thus helping the
physicians to make more informed treatment decisions for
their patients (2,13).
Fig. 3 Severe degree of disease activity. A 55 year old male with remittent course of CD. Axial CTE cuts (A and B) and coronal
reformatted image (C) show wall thickening and mucosal hyper enhancement at the terminal ileum (white arrows), engorged vasa recta
producing the comb sign (red arrow), and enlarged lymph nodes (black arrows).
Fig. 4 Severe degree of disease activity. A 48 year old female with CD. Axial CTE (A) and coronal reformatted image (B) showing wall
thickening and mucosal hyper enhancement of the ileal loops (white arrows), engorged vasa recta and increased density of the peri-enteric
fat (red arrows).
356 A.M. Mohamed et al.Our study comprised patients clinically proven as Crohn’s
disease with suspected activity based on CDAI. We considered
the CTE ﬁndings for activity in the presence of any of the
following: mucosal enhancement, bowel wall thickening
>3 mm, edema of the mesenteric fat, engorged vasa recta,
and lymphadenopathy.
Bowel wall enhancement was present in almost all our cases
(96%). Previous studies done by Choi et al. (14), and Koh et
al. (15), using either CT or MRI, have validated the ability
of mural enhancement in the terminal ileum to detect active
small bowel inﬂammation. Also bowel enhancement has been
used to monitor patients with CD before and after anti-inﬂam-
matory therapy (16).We categorized cases in our study as severe disease in the
presence of engorged vasa recta, increased density/smudging
of peri-enteric fat or enlarged lymph nodes. Meyers andMcGu-
ire (17) referred to tortuosity and dilatation of the ileal vessels
as ‘‘vascular jejunisation of the ileum’’ or the ‘‘comb sign’’ not-
ing the occurrence of this ﬁnding in patients with active CD. In
agreement with them, engorged vasa recta (comb sign) were
present in 14 cases in our study (53%) and is correlated with
histological inﬂammation severity in 12 cases (Figs. 3 and 4).
Lee et al. (18) analyzed 33 patients with CD using endo-
scopic and pathological examination as well as barium enema
and abdominal CT, and reported that CRP and length of hos-
pitalization correlated with the presence of the ‘‘comb sign’’.
Fig. 5 Severe disease activity at CTE but histologically moderate degree. A 43 year old male with remittent course of CD. Axial CTE
cuts (A and B) and coronal reformatted image (C) show wall thickening and mucosal hyper enhancement at the ileo-cecal junction (white
arrow) with stranding and increased density of the peri-colic fat (red arrows).
Fig. 6 Severe CD with stricture formation. 31 year old male with active Crohn’s disease. Axial CTE (A) and coronal reformatted image
(B) show segmental mural thickening of the jejunum at the left lumbar region with luminal narrowing mounting to stricture formation
(white arrows). The adjacent mesenteric fat is edematous with engorged vasa recta (red arrow). The stenotic segment was resected and
histology conﬁrmed severe active disease.
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another characteristic feature of CD. In our study we as-
sessed the mesenteric fat adjacent to the affected bowel loop
for increased density and smudging, which is believed to rep-
resent edema and inﬁltration of inﬂammatory cells in the
peri-enteric fat. Increased fat density was present in 19 pa-
tients (75%) of our cases (Fig. 3 and 5) and correlated with
the disease severity in 16 of them. Correlating with our radio-
logical ﬁndings, Yamamoto et al. (19) recently found signiﬁ-
cant inﬁltration of inﬂammatory cells in hypertrophied
mesenteric adipose tissue adjacent to the involved intestine
in patients with CD. Inﬂammatory cells were mainly CD68positive and CD3 positive T lymphocytes, suggesting that in-
ﬂamed mucosa and its adjacent mesentery share a common
inﬂammation in CD.
In a study by Johnson et al. (11), including 35 cases with
proven colitis at colonoscopy, sensitivities of CTE for detec-
tion of mild, moderate and severe disease were 67%, 90%
and 100%, respectively, on the basis of deﬁning mild disease
in cases with only mucosal hyper enhancement, moderate
disease with mucosal hyper enhancement and wall thickening,
and severe disease with moderate activity criteria plus peri-co-
lonic soft tissue stranding, concluding that sensitivity was best
for detecting moderate and severe disease.
Table 1 Association between detailed CT scan ﬁndings and histological ﬁndings among our 26 Crohn’s disease patients.
Histological ﬁndings n (%) P value
Moderate (n= 10) Severe (n= 16)
Detailed CT ﬁndings
Mucosal enhancement 9 (90) 16 (100) 0.631 NS
Wall thickening 8 (80) 16 (100) 0.138 NS
Engorged vasa recta 2 (20) 12 (75) 0.009*
Fat edema 3 (30) 16 (100) <0.001*
Lymph nodes 1 (10) 8 (50) 0.045*
No statistically signiﬁcant difference in mucosal enhancement and wall thickening has been found between moderate and severe disease stage as
assessed by histopathologic result, while engorged vasa recta, fat edema and lymph nodes had successfully discriminated between moderate and
severe histological ﬁndings. In other words, mucosal enhancement and wall thickening are not good predictors of histological ﬁndings.
* Signiﬁcant.
Table 2 Correlation between CT scan ﬁndings and histolog-
ical ﬁndings among our 26 patients with Crohn’s disease.
Histological ﬁndings n (%) P value
Moderate (n= 10) Severe (n= 16)
CT scan grading
Mild disease 1 (10) 0 (0) 0.125
Moderate disease 5 (50) 0 (0)
Severe disease 4 (40) 16 (100)
McNemar test P= 0.125. NS denoting no signiﬁcant agreement
between CT and histologic result when we considered the presence
of any of engorged vasa recta, fat edema or lymph nodes as
‘‘severe’’.
Table 3 Correlation between CT ﬁndings and histological
ﬁndings if we consider the presence of any two of the following:
engorged vasa recta, fat edema and enlarged lymph nodes as
‘‘severe’’:
Histological ﬁndings n (%) P value
Moderate (n= 10) Severe (n= 16)
CT-scan grading
Mild disease 1 (10) 0 (0) <0.001*
Moderate disease 8 (80) 0 (0)
Severe disease 1 (10) 16 (100)
McNemar test P< 0.001 denoting a signiﬁcant agreement between
CT and endoscopic classiﬁcation of Crohn’s disease severity cases
when we considered the presence of two of either engorged vasa
recta, fat edema or enlarged lymph nodes as ‘‘severe’’.
* Signiﬁcant.
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ings in predicting the degree of activity of CD highly correlated
with the histopathological results. When we considered the
presence of any of engorged vasa recta, fat edema, or lymph
node enlargement to diagnose severe disease, all severe cases
were correctly diagnosed (100%). Moderate disease was diag-
nosed correctly in 50% of cases on the basis of the presence of
mucosal hyper enhancement and bowel wall thickening
>3 mm, while 40% were over graded as severe and McNemar
test revealed no signiﬁcant agreement between CT ﬁndings and
histological results. So we found that if we recondition thepresence of two criteria rather than only one to diagnose severe
disease, the correlation with histological results would be of
greater sensitivity in predicting moderate disease activity
(80%).
Larger studies have also shown that ﬁndings of CD at CTE
correlated highly with endoscopy. In a study of 96 patients
who underwent CTE and ileoscopy, the authors reported that
bowel wall thickening and enhancement on CTE correlated
signiﬁcantly (P< 0.001) with ileoscopic and histological ﬁnd-
ings of active CD (16). In our study, there was no statistically
signiﬁcant difference in mucosal enhancement and wall thick-
ening between moderate and severe disease stage as assessed
by histology, while engorged vasa recta, fat edema and lymph
nodes had successfully discriminated between moderate and
severe endoscopic ﬁndings with P value 0.009, <0.001 and
0.045, respectively.
5. Conclusion
CT enterography is a sensitive and speciﬁc imaging modality
for evaluating the small bowel in patients with Crohn’s disease,
because of its accuracy and non-invasive nature. This study
highlights its ability to assess the degree of activity of the dis-
ease, rendering it the method of choice to monitor patient’s re-
sponse to treatment, avoiding the risk and inconvenience of
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